• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Oshi Health Secures $23M to Expand Virtual Gastrointestinal Care

by Fred Pennic 10/12/2021 Leave a Comment

Oshi Health Secures $23M to Expand Virtual Gastrointestinal Care

What You Should Know: 

– Oshi Health, a virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, today announced it has secured $23M in Series A funding. The round was co-led by Flare Capital Partners, Bessemer Venture Partners and Frist Cressey Ventures with a strategic investment from CVS Health Ventures.  Takeda Digital Ventures, which has funded the company since its inception, also participated in the round along with several noteworthy health industry veterans, including athenahealth co-founder Jonathan Bush, Nat Turner and Zach Weinberg of Operator Partners and Flatiron Health, serial healthcare entrepreneur and IBD patient advocate Eric M. Stone, and Russell Glass the CEO of Headspace Health.

– The funds will be used to rapidly scale Oshi Health’s groundbreaking virtual-first, integrated approach to GI care delivery. Oshi Health’s evidence-based, whole-person care protocols can diagnose patients and provide treatment, including often-neglected dietary and psychosocial interventions. The company’s virtual, continuous care model is improving medical outcomes and quality of life for members while lowering costs for employers and healthcare consumers.

GI Health: The Silent Epidemic

Digestive health issues are shockingly prevalent with one in five working-age adults suffering from a diagnosed GI condition, and much more living with undiagnosed or untreated illness. Oshi Health was launched in 2020 to improve the lives of people with gastrointestinal diseases. Oshi Health has redesigned GI care for the modern world, filling the significant gaps in diagnosis and evidence-based therapies that traditional GI practices are not structured or incentivized to provide.

In a transformational and high-touch 3- to 6-month program, an integrated Oshi Health care team will diagnose symptoms, identify triggers and guide patients to achieve lasting symptom relief. Long-term, Oshi Health remains the first line of support when questions arise or symptoms flare, helping avoid ER visits and expensive escalations in medication, testing and procedures.

Tagged With: Oshi Health, Virtual Care, Virtual Care Platform

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |